Advertisement

Polypharmacy in Nursing Homes

Published:September 11, 2022DOI:https://doi.org/10.1016/j.cger.2022.05.007

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Geriatric Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. 10th edition. Geriatrics review syllabus: a core curriculum in geriatric medicine. American Geriatrics Society, New York, N.Y.2019: 218-230
        • Payne R.A.
        The epidemiology of polypharmacy.
        Clin Med (Lond). 2016; 16: 465-469
        • Tamura B.K.
        • Bell C.L.
        • Inaba M.
        • et al.
        Outcomes of polypharmacy in nursing home residents.
        Clin Geriatr Med. 2012; 28: 217-236
        • Centers for Medicare & Medicaid Services
        Nursing home data compendium 2015 edition.
        HHS Guidance Repository, 2020
        • Burt J.
        • Elmore N.
        • Campbell S.M.
        • et al.
        Developing a measure of polypharmacy appropriateness in primary care: systematic review and expert consensus study.
        BMC Med. 2018; 16 (Published 2018 Jun 13): 91
        • Harris-Kojetin L.
        • Sengupta M.
        • Lendon J.P.
        • et al.
        Long-term care providers and services users in the United States, 2015–2016. National Center for Health Statistics.
        Vital Health Stat. 2019; 3
        • Dwyer L.L.
        • Han B.
        • Woodwell D.A.
        • et al.
        Polypharmacy in nursing home residents in the United States: results of the 2004 national nursing home survey.
        Am J Geriatr Pharmacother. 2010; 8: 63-72
        • Davies E.A.
        • O'Mahony M.S.
        Adverse drug reactions in special populations - the elderly.
        Br J Clin Pharmacol. 2015; 80: 796-807
        • Wastesson J.W.
        • Morin L.
        • Tan E.C.K.
        • et al.
        An update on the clinical consequences of polypharmacy in older adults: a narrative review.
        Expert Opin Drug Saf. 2018; 17: 1185-1196
        • Maclagan L.C.
        • Maxwell C.J.
        • Gandhi S.
        • et al.
        Frailty and potentially inappropriate medication use at nursing home transition.
        J Am Geriatr Soc. 2017; 65: 2205-2212
        • Chhabra P.T.
        • Rattinger G.B.
        • Dutcher S.K.
        • et al.
        Medication reconciliation during the transition to and from long-term care settings: a systematic review.
        Res Social Adm Pharm. 2012; 8: 60-75
        • Visser A.G.R.
        • Schols J.M.G.A.
        • Prevoo M.A.L.M.
        • et al.
        Deprescribing statins and proton pump inhibitors in nursing home residents; a pragmatic exploratory study.
        Gerontol Geriatr Med. 2021; 7 (23337214211050807)
        • By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel
        American geriatrics society 2019 updated ags beers criteria® for potentially inappropriate medication use in older adults.
        J Am Geriatr Soc. 2019; 67: 674-694
        • Khodyakov D.
        • Ochoa A.
        • Olivieri-Mui B.L.
        • et al.
        Screening tool of older person's prescriptions/screening tools to alert doctors to right treatment medication criteria modified for U.S. nursing home setting.
        J Am Geriatr Soc. 2017; 65: 586-591
        • O'Mahony D.
        STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress.
        Expert Rev Clin Pharmacol. 2020; 13: 15-22
        • Thompson W.
        • Farrell B.
        Deprescribing: what is it and what does the evidence tell us?.
        Can J Hosp Pharm. 2013; 66: 201-202
      2. Deprescribing guidelines and algorithms.
        (Available at:) (Accessed January 2022)
        • Hoel R.W.
        • Giddings Connolly R.M.
        • Takahashi P.Y.
        Polypharmacy management in older patients.
        Mayo Clin Proc. 2021; 96: 242-256
        • Kua C.H.
        • Mak V.S.L.
        • Huey Lee S.W.
        Health Outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis.
        J Am Med Dir Assoc. 2019; 20: 362-372.e11
        • Farrell B.
        • Mangin D.
        Deprescribing is an essential part of good prescribing.
        Am Fam Physician. 2019; 99: 7-9
        • Maust D.T.
        • Langa K.M.
        • Blow F.C.
        • et al.
        Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA.
        Int J Geriatr Psychiatry. 2017; 32: 164-174
        • Hanlon J.T.
        • Handler S.M.
        • Castle N.G.
        Antidepressant prescribing in US nursing homes between 1996 and 2006 and its relationship to staffing patterns and use of other psychotropic medications.
        J Am Med Dir Assoc. 2010; 11: 320-324
        • Thakur M.
        • Blazer D.G.
        Depression in long-term care.
        J Am Med Dir Assoc. 2008; 9: 82-87
        • Bourgeois J.
        • Elseviers M.M.
        • Van Bortel L.
        • et al.
        The use of antidepressants in Belgian nursing homes: focus on indications and dosages in the PHEBE study.
        Drugs Aging. 2012; 29: 759-769
        • Guina J.
        • Merrill B.
        Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives.
        J Clin Med. 2018; 7 (Published 2018 Jan 30): 17
        • Rijksen D.O.C.
        • Zuidema S.U.
        • de Haas E.C.
        Use of benzodiazepines and Z-drugs in nursing home residents with dementia: prevalence and appropriateness.
        J Alzheimers Dis Rep. 2021; 5 (Published 2021 Dec 9): 871-879
        • Chiu Y.
        • Bero L.
        • Hessol N.A.
        • et al.
        A literature review of clinical outcomes associated with antipsychotic medication use in North American nursing home residents.
        Health Policy. 2015; 119: 802-813
        • Moth A.E.
        • Hølmkjær P.
        • Holm A.
        • et al.
        What makes deprescription of psychotropic drugs in nursing home residents with dementia so challenging? a qualitative systematic review of barriers and facilitators.
        Drugs Aging. 2021; 38: 671-685
        • Chatterjee S.
        • Bali V.
        • Carnahan R.M.
        • et al.
        Anticholinergic burden and risk of cognitive impairment in elderly nursing home residents with depression.
        Res Social Adm Pharm. 2020; 16: 329-335
        • López-Álvarez J.
        • Sevilla-Llewellyn-Jones J.
        • Agüera-Ortiz L.
        Anticholinergic drugs in geriatric psychopharmacology.
        Front Neurosci. 2019; 13: 1309
        • Fosnes G.S.
        • Lydersen S.
        • Farup P.G.
        Drugs and constipation in elderly in nursing homes: what is the relation?.
        Gastroenterol Res Pract. 2012; 2012: 290231
        • Elli C.
        • Novella A.
        • Nobili A.
        • et al.
        Laxative agents in nursing homes: an example of prescribing cascade.
        J Am Med Dir Assoc. 2021; 22: 2559-2564
        • Farrell B.
        • Pottie K.
        • Thompson W.
        • et al.
        Deprescribing proton pump inhibitors: evidence-based clinical practice guideline.
        Can Fam Physician. 2017; 63: 354-364
        • Boockvar K.S.
        • Song W.
        • Lee S.
        • et al.
        Hypertension treatment in us long-term nursing home residents with and without dementia.
        J Am Geriatr Soc. 2019; 67: 2058-2064
        • Vu M.
        • Schleiden L.J.
        • Harlan M.L.
        • et al.
        Hypertension management in nursing homes: review of evidence and considerations for care.
        Curr Hypertens Rep. 2020; 22 (Published 2020 Jan 14): 8
        • American Geriatrics Society
        Ten things clinicians and patients should question. choosing wisely.
        (Available at:) (Accessed January 2022)
        • Aspinall S.L.
        • Hanlon J.T.
        • Niznik J.D.
        • et al.
        Deprescribing in older nursing home patients: focus on innovative composite measures for dosage deintensification.
        Innov Aging. 2017; 1 (Published 2017 Dec 20): igx031
        • Munshi M.N.
        • Florez H.
        • Huang E.S.
        • et al.
        Management of diabetes in long-term care and skilled nursing facilities: a position statement of the american diabetes association.
        Diabetes Care. 2016; 39: 308-318
        • American Diabetes Association Professional Practice Committee
        13. Older Adults: Standards of Medical Care in Diabetes—2022.
        Diabetes Care. 2022; 45: 195-207https://doi.org/10.2337/dc22-S013
        • Benetos A.
        • Rossignol P.
        • Cherubini A.
        • et al.
        Polypharmacy in the aging patient: management of hypertension in octogenarians [published correction appears in JAMA.
        JAMA. 2015; 314: 628
        • Mack D.S.
        • Tjia J.
        • Hume A.L.
        • et al.
        Prevalent statin use in long-stay nursing home residents with life-limiting illness.
        J Am Geriatr Soc. 2020; 68: 708-716
        • Alcusky M.
        • Lapane K.L.
        Treatment of atrial fibrillation in nursing homes: a place for direct acting oral anticoagulants?.
        J Nurs Home Res Sci. 2018; 4: 15-19
        • Niznik J.D.
        • Zhao X.
        • He M.
        • et al.
        Risk for health events after deprescribing acetylcholinesterase inhibitors in nursing home residents with severe dementia.
        J Am Geriatr Soc. 2020; 68: 699-707
        • Niznik J.D.
        • Zhao X.
        • He M.
        • et al.
        Factors associated with deprescribing acetylcholinesterase inhibitors in older nursing home residents with severe dementia.
        J Am Geriatr Soc. 2019; 67: 1871-1879
        • Lun P.
        • Tang J.Y.
        • Lee J.Q.
        • et al.
        Barriers to appropriate prescribing in older adults with multimorbidity: a modified Delphi study.
        Aging Med (Milton). 2021; 4: 180-192